Superior Ophthalmic Vein Congestion in Thyroid Eye Disease: Assessment With 3D T1-Weighted Imaging and Association With Intravenous Glucocorticoid Therapy Outcomes.
Аннотация
BACKGROUND
3D T1 may assess the superior ophthalmic vein (SOV) congestion, yet its role in the intravenous glucocorticoid (IVGC) therapy remains unclear.
PURPOSE: To evaluate SOV congestion by 3D T1 in thyroid eye disease (TED) and explore its correlation with IVGC therapeutic response.
STUDY TYPE: Retrospective.
SUBJECTS: One hundred thirty-three TED patients, classified as 80 IVGC responders (45.7 ± 10.9 years, 32 males) and 53 non-responders (47.6 ± 9.7 years, 23 males); 290 healthy controls (HCs) (47.9 ± 16.4 years, 145 males).
FIELD STRENGTH/SEQUENCE: 3 T; 3D T1-weighted spoiled gradient-recalled echo, T2 iterative decomposition of water and fat with echo asymmetric and least-squares estimation, and fat-suppressed (FS) T2 mapping.
ASSESSMENT: The SOV diameter (mm), along with the volume ratio, FS T2 relaxation time (T2RT [ms]), and water fraction (WF [%]) of the extraocular muscles (EOMs) and orbital fat (OF) were manually measured.
STATISTICAL TESTS: Student's t-test, Mann-Whitney U test, one-way analysis of variance, interclass correlation coefficient, and correlation analysis. p < 0.05 defined statistical significance.
RESULTS
TED patients presented significantly larger SOV diameters than HCs (2.21 ± 0.45 vs. 1.72 ± 0.26). Among them, the responsive group had significantly larger baseline SOV diameters (2.26 ± 0.49 vs. 2.15 ± 0.39), along with higher FS T2RT (71.30 ± 14.32 vs. 67.65 ± 13.33) and WF (79.31 ± 13.68 vs. 75.17 ± 14.47) in the EOMs compared to the nonresponsive group. The SOV diameter demonstrated moderate-to-good positive correlations with FS T2RT (r = 0.59) and WF (r = 0.67) in responders. Following IVGC therapy, a significant reduction in SOV diameter was observed exclusively in the responsive group (2.26 ± 0.49 vs. 1.98 ± 0.47).
DATA
CONCLUSION
Patients exhibiting more severe SOV congestion showed a better response to IVGC therapy, potentially due to an enhanced inflammatory state in the EOMs.
EVIDENCE LEVEL: 4.
TECHNICAL EFFICACY: Stage 4.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.